Flu shots just got clearer
This week’s article leads with the new Pediatrics study showing strong estimated protection against pediatric flu death, then translates current CDC flu surveillance into practical fall planning for families. It also explains why families should not wait for Moderna’s pending mRNA flu shot decision, how same-day flu/COVID vaccination safety data affects scheduling, and what to check next for measles, H5 bird flu, and ACIP-related coverage uncertainty.
Flu is quiet right now, but the strongest family signal this week came from a new Pediatrics study: among 1,234 laboratory-confirmed pediatric flu deaths from August 2016 through July 2025, flu vaccination was associated with an estimated 80% lower risk of flu-related death in children ages 6 months through 17 years. 1
That is the decision point for families. This week does not call for panic, and it does not call for waiting. It calls for getting household records in order now, so fall flu vaccination is easy when appointments open.
The child flu-shot evidence got stronger
The Pediatrics study used a case-cohort design, which means researchers compared children who died from lab-confirmed flu with a sampled comparison group to estimate how vaccination changed risk. 1 The estimated protection was 80% overall, with a 95% confidence interval of 75% to 84%; a confidence interval is the range in which researchers estimate the true effect probably falls. 1
The study also matters because protection was seen in both groups families worry about. Children with underlying medical conditions had estimated vaccine effectiveness of 77%, and children without known underlying conditions had estimated vaccine effectiveness of 87%. 1 In plain English, flu vaccination was associated with much lower death risk even among children who did not already look medically fragile.
The current season is no longer surging. CDC FluView for Week 25, the week ending June 27, reported no new pediatric flu deaths for that week, and the 2025-2026 season total stayed at 184. 2 That quiet week should not erase the larger lesson from the new study: severe outcomes are uncommon, but vaccination is one of the few steps families can take before exposure.
Summer flu is low, but close-contact risk is different
CDC described seasonal flu activity as low in Week 25. Influenza-like illness fell to 1.0%, down from 1.1% the prior week, and clinical laboratories found flu in 0.5% of tested respiratory specimens, with 122 positives among 25,697 tests. 2 Emergency-department visits with an influenza discharge diagnosis were 0.1% nationally. 2
The strain mix matters for fall planning. Influenza B made up 49.2% of clinical-lab positives, or 60 of 122 positives, in Week 25. 2 Influenza B is one of the major seasonal flu types covered by flu vaccines; its late-season share can rise when overall flu numbers are low.
Low national activity does not mean every setting is low risk. The Lackland Air Force Base outbreak reached 284 confirmed flu cases, four hospitalizations, and one death after flu vaccination became optional for most service members; the Pentagon later restored mandatory flu shots for trainees, while shots remained voluntary for most active-duty personnel. 34
For families, the Lackland lesson is narrower than the politics around it. A child or young adult heading into basic training, a dorm, a residential program, or a crowded camp has a different exposure pattern than a household staying mostly at home. When flu season returns, those close-contact settings make early, ordinary vaccination more valuable.
Do not wait for a newer flu shot
Moderna's mRNA flu vaccine, mRNA-1010 or mFLUSIVA, is the pipeline item to watch. The FDA's Vaccines and Related Biological Products Advisory Committee, known as VRBPAC, voted 9-0 on June 18 that the vaccine's benefits outweigh its risks for adults ages 50 to 64 under traditional approval and adults 65 and older under accelerated approval. 5 The pending FDA action date is August 5, 2026. 6
The science behind that interest is real. A Nature Immunology report on mRNA-1010 found that the mRNA-based flu vaccine induced sustained germinal-center B-cell responses and broadened antibody binding against diverse flu strains. 7 Germinal centers are training sites inside lymph nodes where B cells improve the antibodies they make; broader antibody binding could help a vaccine cover more viral variation.
That does not make mFLUSIVA a reason for families to delay standard fall planning. FDA authorization, CDC recommendation, pharmacy availability, and insurance coverage are separate steps. The same vaccine-policy analysis that reported the VRBPAC vote also noted that without a functioning Advisory Committee on Immunization Practices, or ACIP, no recommendation can be made on who should receive the vaccine or how coverage should work. 5 ACIP is the CDC advisory group that normally turns vaccine evidence into practical US recommendations.
Pfizer does not change the wait-or-book decision this week. As of July 6, Pfizer's press-release archive showed no vaccine-pipeline announcement, and its June releases covered non-vaccine items such as dividends, oncology, hemophilia, metabolic disease, and investor events. 8 A family should not postpone a routine flu shot because of a Pfizer flu-vaccine update that has not publicly arrived.
Same-day scheduling has new safety support
A new Annals of Internal Medicine study gives families another practical scheduling answer. Researchers used Veterans Affairs electronic health record data to compare 705,124 people who received COVID-19 and flu vaccines on the same day with 1,813,205 people who received flu vaccine alone between September 2022 and August 2025. 9
The study found no meaningful increase in three grouped categories of adverse events. The risk ratio was 1.03 for severe or life-threatening events, 0.99 for clinically significant events, and 0.99 for milder or self-limited events. 9 A risk ratio near 1 means the two groups had similar risk.
This is useful because missed appointments are a real problem for families. If a clinician or pharmacy offers flu and COVID-19 vaccines at the same visit for an eligible household member, the new study supports treating that as a reasonable convenience rather than a shortcut. People with a history of serious vaccine reactions or a complex medical situation should still ask their clinician how to schedule.
Other checks for this week
Measles is still the vaccine-record check that should happen before travel. CDC reported 2,170 confirmed US measles cases as of July 2, with 31 outbreaks and 41 affected jurisdictions. 10 CDC also reported that 93% of cases were outbreak-associated and that 93% were in people who were unvaccinated or whose vaccination status was unknown. 10 Before a trip, families should verify measles-mumps-rubella, or MMR, records rather than relying on memory.
H5 bird flu did not add a new family action item this week. CDC's July 6 monitoring update said its flu surveillance systems showed no indicators of unusual influenza activity in people, including avian influenza A(H5), and FluView reported no new human infections with avian influenza A(H5) during Week 25. 211 Households with poultry, dairy, or sick-animal exposure should still mention that exposure if someone develops flu-like symptoms.
The policy watchlist is still unsettled. IDSA, PIDS, SHEA, and SIDP said the new ACIP charter changes the committee's focus, membership structure, and governance in ways that could lead to confusion and delays in vaccine access. 12 That matters less for shots already covered under standing recommendations and more for new or updated products that need a clean recommendation path.
What families can do now
- Check every child's flu-vaccine record before school-year planning starts. The new Pediatrics study found estimated vaccine effectiveness against pediatric flu death of 80% overall across nine flu seasons. 1
- Plan fall flu vaccination when appointments are available and easy to keep. Week 25 flu activity is low, but routine planning now prevents a rushed decision when school, work, and respiratory-virus season collide. 2
- Use same-day flu and COVID-19 vaccination when it solves a scheduling problem and the vaccinating clinician agrees. The new VA study did not find a significant increase in the major adverse-event groupings it measured. 9
- Check MMR records before travel. The national measles count is still rising, and most cases are tied to people who are unvaccinated or whose status is unknown. 10
Cover image: CDC FluView banner from Weekly US Influenza Surveillance Report: Week 25.
References
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Pfizer: Press Release Archive
pfizer.com
- 9
- 10
- 11
- 12IDSA: New ACIP charter will delay vaccine access
idsociety.org
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.